account_balance
Investment manager · 13F filer · SEC CIK 938206
Driehaus Capital Management LLC
Reported value$17.3Bas of Jun 30, 2026
Positions354 84 new, 85 sold out
Top 10 weight16.3%TSM alone is 3%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
TSMTSMC
2.7%Trimmed −22%
DFTXDefinium Therapeutics Inc
1.9%Added +16%
PRAXPraxis Precision Medicines Inc
1.9%
XENEXenon Pharmaceuticals Inc
1.5%
SIMOSilicon Motion Technology Corp
1.5%Added +54%
SYRESpyre Therapeutics Inc
1.4%
CRNXCrinetics Pharmaceuticals Inc
1.4%
APGEApogee Therapeutics Inc
1.3%Trimmed −9%
GHGuardant Health Inc
1.3%
PLPlanet Labs PBC
1.3%Trimmed −15%
BAPCredicorp Ltd
1.3%Added +24%
EWTXEdgewise Therapeutics Inc
1.1%Added +6%
TSMTSMC
2.7%Trimmed −22%
DFTX1.9%PRAX1.9%XENE1.5%SIMO1.5%SYRE1.4%CRNX1.4%
APGE1.3%
GH1.3%PL1.3%BAP1.3%EWTX1.1%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
TSM TSMC 2.7% Trimmed −22%DFTX Definium Therapeutics Inc 1.9% Added +16%PRAX Praxis Precision Medicines Inc 1.9% HeldXENE Xenon Pharmaceuticals Inc 1.5% HeldSIMO Silicon Motion Technology Corp 1.5% Added +54%SYRE Spyre Therapeutics Inc 1.4% Held
CRNX Crinetics Pharmaceuticals Inc 1.4% Held
APGE Apogee Therapeutics Inc 1.3% Trimmed −9%
GH Guardant Health Inc 1.3% HeldPL Planet Labs PBC 1.3% Trimmed −15%BAP Credicorp Ltd 1.3% Added +24%EWTX Edgewise Therapeutics Inc 1.1% Added +6%What changed